Business
How two companies sprinted ahead in the extraordinary race for a COVID vaccine – Sydney Morning Herald
Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer chief Albert Bourla called on his top vaccine scientists and laid…
What followed was a full-bore effort carried out under strict coronavirus lockdown conditions, . On November 9, Pfizer and its German partner BioNTech SE reported the first promising results from large-scale, scientifically rigorous clinical trials around the world followed by US biotech Moderna announcing its own successful trial – although potential roadblocks remain and widespread distribution is not expected until at least April.
Both companies have reported preliminary findings of more than…
-
General14 hours agoFrench far-right supporters rally against Le Pen conviction in Paris
-
Business5 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business9 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
General24 hours agoFederal Labor makes $100m Canberra convention centre funding pledge for planning, new aquatic centre